NCT03395080 2025-08-01
P204
Leap Therapeutics, Inc.
Phase 2 Completed
Clinical Trials
6 trialsNCT00506779 2020-11-18
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT00231868 2020-08-12
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Montefiore Medical Center
Phase 2 Completed
NCT00584909 2017-01-27
A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus
University of Alabama at Birmingham
Phase 2 Terminated
NCT00502203 2016-05-09
Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00626561 2014-07-07
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
M.D. Anderson Cancer Center
Phase 2 Terminated